HCA Healthcare Lowers Guidance Amid Exchange Disruption

HCA Healthcare recently issued a warning regarding its financial performance, as its second-quarter results revealed that the disruption from the end of enhanced Affordable Care Act exchange subsidies is more pronounced than initially anticipated. This anticipated change has prompted the major for-profit health system to downgrade its guidance for the fiscal year 2026.

The company noted an observable shift in its payer mix, closely linked to an influx of uninsured patients, primarily due to lost coverage on health insurance exchanges. This shift has led to an estimated pre-tax impact of approximately $400 million in the second quarter alone. This figure exceeds HCA's previous forecasts, indicating a $75 million increase in its assessments from the first quarter.

In an earlier statement from April, HCA had projected a full-year adverse impact ranging between $600 million and $900 million due to these payer mix shifts. However, the current outlook suggests a revised estimate of a $1 billion to $1.2 billion negative influence on its financials.

As a result of these developments, HCA Healthcare has altered several key aspects of its financial guidance. Although the new revenue guidance remains within a similar range—now set at $77 billion to $79.5 billion—other metrics such as net income and adjusted EBITDA have seen downward revisions. The updated forecast for net income now sits between $6.3 billion and $6.7 billion, compared to the earlier expectations of $6.5 billion to $7 billion. Meanwhile, the adjusted EBITDA guidance has been changed from a previous range of $15.6 billion to $16.5 billion down to $15.4 billion to $16.1 billion. Furthermore, earnings per diluted share guidance has also been lowered, now ranging from $28.70 to $30.50 instead of the previously estimated $29.10 to $31.50.

HCA's CEO, Sam Hazen, expressed gratitude towards employees for their efforts in navigating the various challenges affecting the company during the first half of the year. He mentioned that the adjustments to guidance reflect these factors while maintaining confidence in HCA's ability to adapt to the changing landscape, focusing on patient care, and following through on strategic plans aimed at digitization and expansion of their service networks.

In the stock market, HCA shares reflected this downward adjustment, trading about 6% to 7% lower than their opening values. The decrease prompted similar declines among its for-profit healthcare peers, including Tenet Healthcare, Community Health Systems, and Universal Health Services. Analysts had expressed significant concern about the exchanges' instability when engaging with company leaders during the Q1 earnings calls conducted back in April.

In addition to the challenges presented by the changes in the insurance exchanges, HCA also reported a decline in certain surgical services, though the implications of this decline appear less severe compared to the overall payer mix impacts. Specifically, inpatient surgeries at the same facilities experienced a drop of 2.3% year over year, while outpatient surgeries decreased by 3.4%.

Despite these challenges, not all facets of HCA's preliminary results were negative. The organization recorded increases in several operational metrics, including same-facility admissions, which rose by 2.5%, same-facility equivalent admissions by 2.7%, and same-facility emergency room visits by 3.6%.

Moreover, HCA revealed the recognition of about $400 million in additional net benefits from Medicaid Supplemental Payment Programs in the second quarter. This increase is credited to Florida's state-directed payment program approval, which is expected to contribute positively to its financial standing.

Looking ahead, HCA now forecasts an additional $300 million to $500 million in Medicaid supplemental payments for the year compared to the previous year. This forecast contrasts sharply with prior projections that anticipated a negative impact ranging between -$50 million and -$250 million, earlier estimates that deliberately excluded uncertainties tied to supplemental funding programs, including Florida’s, which were not guaranteed.

In terms of financial expectations for the second quarter, HCA forecasts revenue reaching approximately $20.2 billion, an increase from the $18.6 billion recorded in the same timeframe last year. The anticipated net income for the quarter is expected to be around $1.7 billion, equating to $7.62 per diluted share, which surpasses last year's second quarter income of $1.65 billion, or $6.83 per diluted share.

Additionally, HCA Healthcare has announced plans to hold its second-quarter earnings call on July 24. In the preceding days, the healthcare earnings reporting season will begin, with Community Health Systems set to release its figures on the afternoon of July 22, followed by insurer Elevance Health, which will kick off the reporting with its earnings on Wednesday.